Olga E Andreeva

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Venues

Investigational new drugs

Chemistry & biodiversity

Molecules (Basel, Switzerland)

BioImpacts : BI

Rossijskij onkologiceskij naucnyj centr imeni N N Blohina

Rossijskij onkologiceskij naucnyj centr imeni N N Blohina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rossijskij onkologiceskij naucnyj centr imeni N N Blohina Sep 01 2012

Russia

researcher :: laboratory of molecular endocrinology

Education History

Rossijskij onkologiceskij naucnyj centr imeni N N Blohina Sep 01 2009 - Jun 01 2012

Russia

PHD :: institute of carcinogenesys

Publications

Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs 41 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Yuri Yu Shchegolev, Danila V Sorokin, Alexander M Scherbakov, Olga E Andreeva, Diana I Salnikova, Ekaterina I Mikhaevich, Margarita V Gudkova, Mikhail A Krasil'nikov
Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells. BioImpacts : BI 13 (4) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs 41 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs 41 (1) (2023)
Alexander M Scherbakov, Svetlana K Vorontsova, Alvina I Khamidullina, Jasminka Mrdjanović, Olga E Andreeva, Fedor B Bogdanov, Diana I Salnikova, Vladimir Jurišić, Igor V Zavarzin, Valerii Z Shirinian
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. Investigational new drugs (2023)
Olga E Andreeva, Yuri Yu Shchegolev, Alexander M Scherbakov, Ekaterina I Mikhaevich, Danila V Sorokin, Margarita V Gudkova, Irina V Bure, Ekaterina B Kuznetsova, Dmitry S Mikhaylenko, Marina V Nemtsova, Dmitry Vladimirovich Bagrov, Mikhail A Krasil'nikov
Secretion of Mutant DNA and mRNA by the Exosomes of Breast Cancer Cells. Molecules (Basel, Switzerland) 26 (9) (2021)
Alexander M Scherbakov, Olga V Stasevich, Diana I Salnikova, Olga E Andreeva, Ekaterina I Mikhaevich
Antiestrogenic and antiproliferative potency of secoisolariciresinol diglucoside derivatives on MCF-7 breast cancer cells. Natural product research 35 (24) (2020)
Alexander M Scherbakov, Vladimir N Zhabinskii, Vladimir A Khripach, Dmitrii S Shcherbinin, Arif R Mekhtiev, Yuri Yu Shchegolev, Aleh P Savochka, Olga E Andreeva
Biological Evaluation of a New Brassinosteroid: Antiproliferative Effects and Targeting Estrogen Receptor α Pathways. Chemistry & biodiversity 16 (9) (2019)

Olga E Andreeva.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Olga E Andreeva